Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.78 Insider Own12.87% Shs Outstand67.89M Perf Week-6.12%
Market Cap78.50M Forward P/E- EPS next Y-1.37 Insider Trans-0.17% Shs Float59.48M Perf Month-33.91%
Income-120.23M PEG- EPS next Q-0.42 Inst Own42.30% Short Float6.01% Perf Quarter-40.41%
Sales0.00M P/S- EPS this Y8.19% Inst Trans1.19% Short Ratio11.57 Perf Half Y-50.85%
Book/sh1.80 P/B0.64 EPS next Y14.73% ROA-54.09% Short Interest3.57M Perf Year-77.45%
Cash/sh1.57 P/C0.73 EPS next 5Y- ROE-68.07% 52W Range1.17 - 5.49 Perf YTD-48.89%
Dividend Est.- P/FCF- EPS past 5Y-73.43% ROI-78.17% 52W High-79.06% Beta-0.30
Dividend TTM- Quick Ratio8.46 Sales past 5Y0.00% Gross Margin- 52W Low-1.71% ATR (14)0.11
Dividend Ex-Date- Current Ratio8.46 EPS Y/Y TTM17.22% Oper. Margin0.00% RSI (14)27.52 Volatility7.69% 8.55%
Employees168 Debt/Eq0.28 Sales Y/Y TTM- Profit Margin- Recom1.25 Target Price14.06
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q-5.52% Payout- Rel Volume1.15 Prev Close1.20
Sales Surprise- EPS Surprise-19.11% Sales Q/Q- EarningsMay 09 AMC Avg Volume308.95K Price1.15
SMA20-21.02% SMA50-31.38% SMA200-43.73% Trades Volume353,796 Change-4.17%
Date Action Analyst Rating Change Price Target Change
Jul-26-22Initiated Wedbush Outperform $18
Apr-27-22Initiated Goldman Neutral $6
Dec-17-21Initiated H.C. Wainwright Buy $26
Dec-03-21Initiated Robert W. Baird Outperform $38
Dec-02-21Initiated Oppenheimer Outperform $30
Oct-19-21Initiated JMP Securities Mkt Outperform $40
Mar-25-21Initiated B. Riley Securities Buy $60
Mar-03-21Initiated Evercore ISI Outperform $48
Mar-03-21Initiated Barclays Overweight $56
Mar-02-21Initiated Stifel Buy $58
Jun-04-24 04:01PM
May-13-24 09:22AM
May-09-24 10:54PM
May-06-24 08:00AM
04:01PM Loading…
May-03-24 04:01PM
May-02-24 04:01PM
Apr-04-24 08:32AM
Apr-01-24 08:00AM
Mar-20-24 09:53PM
Mar-05-24 04:01PM
Mar-04-24 08:00AM
Feb-15-24 02:56PM
Feb-07-24 08:00AM
04:01PM Loading…
Feb-02-24 04:01PM
Jan-19-24 08:22AM
Jan-17-24 04:01PM
Dec-21-23 04:01PM
Dec-01-23 04:01PM
Nov-27-23 08:00AM
Nov-09-23 04:01PM
Nov-07-23 04:05PM
Nov-03-23 04:01PM
Nov-02-23 09:01AM
Oct-03-23 04:01PM
Sep-25-23 08:00AM
Aug-30-23 08:00AM
Aug-10-23 04:05PM
08:00AM Loading…
Aug-01-23 08:00AM
Jun-09-23 04:03PM
Jun-05-23 08:00AM
May-11-23 04:05PM
Apr-19-23 02:42PM
Apr-18-23 08:00AM
Mar-28-23 09:55AM
Mar-23-23 04:01PM
Mar-07-23 05:52AM
Feb-21-23 08:00AM
Feb-16-23 02:04PM
Jan-19-23 08:00AM
Jan-12-23 08:00AM
Dec-16-22 06:40PM
Dec-07-22 07:45AM
Nov-30-22 10:35AM
Nov-22-22 08:00AM
Nov-10-22 04:15PM
Nov-01-22 08:00AM
Oct-14-22 10:26AM
Oct-12-22 08:00AM
Oct-11-22 08:00AM
Sep-28-22 08:00AM
Sep-06-22 04:15PM
Sep-01-22 09:55AM
Aug-16-22 09:55AM
Aug-11-22 04:15PM
Aug-01-22 08:00AM
Jun-10-22 08:00AM
Jun-01-22 08:00AM
May-12-22 04:15PM
May-07-22 09:20AM
May-05-22 08:00AM
Apr-25-22 08:00AM
Apr-14-22 04:15PM
Mar-22-22 10:10AM
Mar-14-22 04:30PM
Feb-28-22 08:00AM
Feb-11-22 08:00AM
Jan-04-22 08:00AM
Nov-29-21 08:00AM
Nov-25-21 07:35AM
Nov-19-21 04:01PM
Nov-15-21 10:39AM
Nov-11-21 12:51PM
Nov-10-21 04:10PM
Nov-09-21 08:30AM
Nov-08-21 08:00AM
Nov-04-21 09:15AM
Oct-19-21 07:00AM
Oct-12-21 08:00AM
Sep-09-21 08:00AM
Sep-02-21 08:00AM
Aug-09-21 04:05PM
Jul-08-21 08:00AM
Jun-17-21 08:00AM
Jun-11-21 08:00AM
Jun-10-21 08:00AM
May-25-21 04:10PM
May-07-21 10:30AM
May-06-21 04:08PM
Apr-28-21 08:00AM
Mar-25-21 04:35PM
Mar-05-21 03:00PM
Mar-01-21 03:45PM
Feb-09-21 04:05PM
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Attar Eyal C.CHIEF MEDICAL OFFICERJun 03 '24Sale1.3914,64520,35796,063Jun 04 06:09 PM